 | • レポートコード：GIR-2104Z11925 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、呼吸器感染症診断のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。呼吸器感染症診断の種類別市場規模（機械的試験、画像検査、体外診断（IVD）試験）、用途別市場規模（病院、臨床検査室、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・呼吸器感染症診断の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbott Laboratories、Thermo Fisher Scientific.、Koninklijke Philips、Cardinal Health、COSMED、Smiths Group、NIHON KOHDEN CORPORATION、Becton、Dickinson、F.Hoffmann ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：機械的試験、画像検査、体外診断（IVD）試験 ・用途別分析2016年-2026年：病院、臨床検査室、その他 ・呼吸器感染症診断の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・呼吸器感染症診断のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・呼吸器感染症診断のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・呼吸器感染症診断の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・呼吸器感染症診断の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Respiratory Infectious Disease Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Respiratory Infectious Disease Diagnostics size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Respiratory Infectious Disease Diagnostics market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Respiratory Infectious Disease Diagnostics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Mechanical Tests
Imaging Tests
In Vitro Diagnostics (IVD) Tests
Market segment by Application, can be divided into
Hospitals
Clinical Laboratories
Others
Market segment by players, this report covers
Abbott Laboratories
Thermo Fisher Scientific.
Koninklijke Philips
Cardinal Health
COSMED
Smiths Group
NIHON KOHDEN CORPORATION
Becton
Dickinson
F.Hoffmann
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Respiratory Infectious Disease Diagnostics
1.2 Classification of Respiratory Infectious Disease Diagnostics by Type
1.2.1 Overview: Global Respiratory Infectious Disease Diagnostics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Respiratory Infectious Disease Diagnostics Revenue Market Share by Type in 2020
1.2.3 Mechanical Tests
1.2.4 Imaging Tests
1.2.5 In Vitro Diagnostics (IVD) Tests
1.3 Global Respiratory Infectious Disease Diagnostics Market by Application
1.3.1 Overview: Global Respiratory Infectious Disease Diagnostics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinical Laboratories
1.3.4 Others
1.4 Global Respiratory Infectious Disease Diagnostics Market Size & Forecast
1.5 Global Respiratory Infectious Disease Diagnostics Market Size and Forecast by Region
1.5.1 Global Respiratory Infectious Disease Diagnostics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Respiratory Infectious Disease Diagnostics Market Size by Region, (2016-2021)
1.5.3 North America Respiratory Infectious Disease Diagnostics Market Size and Prospect (2016-2026)
1.5.4 Europe Respiratory Infectious Disease Diagnostics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Respiratory Infectious Disease Diagnostics Market Size and Prospect (2016-2026)
1.5.6 South America Respiratory Infectious Disease Diagnostics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Respiratory Infectious Disease Diagnostics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Respiratory Infectious Disease Diagnostics Market Drivers
1.6.2 Respiratory Infectious Disease Diagnostics Market Restraints
1.6.3 Respiratory Infectious Disease Diagnostics Trends Analysis
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Respiratory Infectious Disease Diagnostics Product and Solutions
2.1.4 Abbott Laboratories Respiratory Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Thermo Fisher Scientific.
2.2.1 Thermo Fisher Scientific. Details
2.2.2 Thermo Fisher Scientific. Major Business
2.2.3 Thermo Fisher Scientific. Respiratory Infectious Disease Diagnostics Product and Solutions
2.2.4 Thermo Fisher Scientific. Respiratory Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Thermo Fisher Scientific. Recent Developments and Future Plans
2.3 Koninklijke Philips
2.3.1 Koninklijke Philips Details
2.3.2 Koninklijke Philips Major Business
2.3.3 Koninklijke Philips Respiratory Infectious Disease Diagnostics Product and Solutions
2.3.4 Koninklijke Philips Respiratory Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Koninklijke Philips Recent Developments and Future Plans
2.4 Cardinal Health
2.4.1 Cardinal Health Details
2.4.2 Cardinal Health Major Business
2.4.3 Cardinal Health Respiratory Infectious Disease Diagnostics Product and Solutions
2.4.4 Cardinal Health Respiratory Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Cardinal Health Recent Developments and Future Plans
2.5 COSMED
2.5.1 COSMED Details
2.5.2 COSMED Major Business
2.5.3 COSMED Respiratory Infectious Disease Diagnostics Product and Solutions
2.5.4 COSMED Respiratory Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 COSMED Recent Developments and Future Plans
2.6 Smiths Group
2.6.1 Smiths Group Details
2.6.2 Smiths Group Major Business
2.6.3 Smiths Group Respiratory Infectious Disease Diagnostics Product and Solutions
2.6.4 Smiths Group Respiratory Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Smiths Group Recent Developments and Future Plans
2.7 NIHON KOHDEN CORPORATION
2.7.1 NIHON KOHDEN CORPORATION Details
2.7.2 NIHON KOHDEN CORPORATION Major Business
2.7.3 NIHON KOHDEN CORPORATION Respiratory Infectious Disease Diagnostics Product and Solutions
2.7.4 NIHON KOHDEN CORPORATION Respiratory Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 NIHON KOHDEN CORPORATION Recent Developments and Future Plans
2.8 Becton
2.8.1 Becton Details
2.8.2 Becton Major Business
2.8.3 Becton Respiratory Infectious Disease Diagnostics Product and Solutions
2.8.4 Becton Respiratory Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Becton Recent Developments and Future Plans
2.9 Dickinson
2.9.1 Dickinson Details
2.9.2 Dickinson Major Business
2.9.3 Dickinson Respiratory Infectious Disease Diagnostics Product and Solutions
2.9.4 Dickinson Respiratory Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Dickinson Recent Developments and Future Plans
2.10 F.Hoffmann
2.10.1 F.Hoffmann Details
2.10.2 F.Hoffmann Major Business
2.10.3 F.Hoffmann Respiratory Infectious Disease Diagnostics Product and Solutions
2.10.4 F.Hoffmann Respiratory Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 F.Hoffmann Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Respiratory Infectious Disease Diagnostics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Respiratory Infectious Disease Diagnostics Players Market Share
3.2.2 Top 10 Respiratory Infectious Disease Diagnostics Players Market Share
3.2.3 Market Competition Trend
3.3 Respiratory Infectious Disease Diagnostics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Respiratory Infectious Disease Diagnostics Revenue and Market Share by Type (2016-2021)
4.2 Global Respiratory Infectious Disease Diagnostics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Respiratory Infectious Disease Diagnostics Revenue Market Share by Application (2016-2021)
5.2 Respiratory Infectious Disease Diagnostics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Respiratory Infectious Disease Diagnostics Revenue by Type (2016-2026)
6.2 North America Respiratory Infectious Disease Diagnostics Revenue by Application (2016-2026)
6.3 North America Respiratory Infectious Disease Diagnostics Market Size by Country
6.3.1 North America Respiratory Infectious Disease Diagnostics Revenue by Country (2016-2026)
6.3.2 United States Respiratory Infectious Disease Diagnostics Market Size and Forecast (2016-2026)
6.3.3 Canada Respiratory Infectious Disease Diagnostics Market Size and Forecast (2016-2026)
6.3.4 Mexico Respiratory Infectious Disease Diagnostics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Respiratory Infectious Disease Diagnostics Revenue by Type (2016-2026)
7.2 Europe Respiratory Infectious Disease Diagnostics Revenue by Application (2016-2026)
7.3 Europe Respiratory Infectious Disease Diagnostics Market Size by Country
7.3.1 Europe Respiratory Infectious Disease Diagnostics Revenue by Country (2016-2026)
7.3.2 Germany Respiratory Infectious Disease Diagnostics Market Size and Forecast (2016-2026)
7.3.3 France Respiratory Infectious Disease Diagnostics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Respiratory Infectious Disease Diagnostics Market Size and Forecast (2016-2026)
7.3.5 Russia Respiratory Infectious Disease Diagnostics Market Size and Forecast (2016-2026)
7.3.6 Italy Respiratory Infectious Disease Diagnostics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Respiratory Infectious Disease Diagnostics Revenue by Type (2016-2026)
8.2 Asia-Pacific Respiratory Infectious Disease Diagnostics Revenue by Application (2016-2026)
8.3 Asia-Pacific Respiratory Infectious Disease Diagnostics Market Size by Region
8.3.1 Asia-Pacific Respiratory Infectious Disease Diagnostics Revenue by Region (2016-2026)
8.3.2 China Respiratory Infectious Disease Diagnostics Market Size and Forecast (2016-2026)
8.3.3 Japan Respiratory Infectious Disease Diagnostics Market Size and Forecast (2016-2026)
8.3.4 South Korea Respiratory Infectious Disease Diagnostics Market Size and Forecast (2016-2026)
8.3.5 India Respiratory Infectious Disease Diagnostics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Respiratory Infectious Disease Diagnostics Market Size and Forecast (2016-2026)
8.3.7 Australia Respiratory Infectious Disease Diagnostics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Respiratory Infectious Disease Diagnostics Revenue by Type (2016-2026)
9.2 South America Respiratory Infectious Disease Diagnostics Revenue by Application (2016-2026)
9.3 South America Respiratory Infectious Disease Diagnostics Market Size by Country
9.3.1 South America Respiratory Infectious Disease Diagnostics Revenue by Country (2016-2026)
9.3.2 Brazil Respiratory Infectious Disease Diagnostics Market Size and Forecast (2016-2026)
9.3.3 Argentina Respiratory Infectious Disease Diagnostics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Respiratory Infectious Disease Diagnostics Revenue by Type (2016-2026)
10.2 Middle East & Africa Respiratory Infectious Disease Diagnostics Revenue by Application (2016-2026)
10.3 Middle East & Africa Respiratory Infectious Disease Diagnostics Market Size by Country
10.3.1 Middle East & Africa Respiratory Infectious Disease Diagnostics Revenue by Country (2016-2026)
10.3.2 Turkey Respiratory Infectious Disease Diagnostics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Respiratory Infectious Disease Diagnostics Market Size and Forecast (2016-2026)
10.3.4 UAE Respiratory Infectious Disease Diagnostics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Respiratory Infectious Disease Diagnostics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Respiratory Infectious Disease Diagnostics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Respiratory Infectious Disease Diagnostics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Respiratory Infectious Disease Diagnostics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Respiratory Infectious Disease Diagnostics Revenue Market Share by Region (2021-2026)
Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Laboratories Major Business
Table 8. Abbott Laboratories Respiratory Infectious Disease Diagnostics Product and Solutions
Table 9. Abbott Laboratories Respiratory Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Thermo Fisher Scientific. Corporate Information, Head Office, and Major Competitors
Table 11. Thermo Fisher Scientific. Major Business
Table 12. Thermo Fisher Scientific. Respiratory Infectious Disease Diagnostics Product and Solutions
Table 13. Thermo Fisher Scientific. Respiratory Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Koninklijke Philips Corporate Information, Head Office, and Major Competitors
Table 15. Koninklijke Philips Major Business
Table 16. Koninklijke Philips Respiratory Infectious Disease Diagnostics Product and Solutions
Table 17. Koninklijke Philips Respiratory Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Cardinal Health Corporate Information, Head Office, and Major Competitors
Table 19. Cardinal Health Major Business
Table 20. Cardinal Health Respiratory Infectious Disease Diagnostics Product and Solutions
Table 21. Cardinal Health Respiratory Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. COSMED Corporate Information, Head Office, and Major Competitors
Table 23. COSMED Major Business
Table 24. COSMED Respiratory Infectious Disease Diagnostics Product and Solutions
Table 25. COSMED Respiratory Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Smiths Group Corporate Information, Head Office, and Major Competitors
Table 27. Smiths Group Major Business
Table 28. Smiths Group Respiratory Infectious Disease Diagnostics Product and Solutions
Table 29. Smiths Group Respiratory Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. NIHON KOHDEN CORPORATION Corporate Information, Head Office, and Major Competitors
Table 31. NIHON KOHDEN CORPORATION Major Business
Table 32. NIHON KOHDEN CORPORATION Respiratory Infectious Disease Diagnostics Product and Solutions
Table 33. NIHON KOHDEN CORPORATION Respiratory Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Becton Corporate Information, Head Office, and Major Competitors
Table 35. Becton Major Business
Table 36. Becton Respiratory Infectious Disease Diagnostics Product and Solutions
Table 37. Becton Respiratory Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Dickinson Corporate Information, Head Office, and Major Competitors
Table 39. Dickinson Major Business
Table 40. Dickinson Respiratory Infectious Disease Diagnostics Product and Solutions
Table 41. Dickinson Respiratory Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. F.Hoffmann Corporate Information, Head Office, and Major Competitors
Table 43. F.Hoffmann Major Business
Table 44. F.Hoffmann Respiratory Infectious Disease Diagnostics Product and Solutions
Table 45. F.Hoffmann Respiratory Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Respiratory Infectious Disease Diagnostics Revenue (USD Million) by Players (2019-2021)
Table 47. Global Respiratory Infectious Disease Diagnostics Revenue Share by Players (2019-2021)
Table 48. Breakdown of Respiratory Infectious Disease Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Respiratory Infectious Disease Diagnostics Players Head Office, Products and Services Provided
Table 50. Respiratory Infectious Disease Diagnostics Mergers & Acquisitions in the Past Five Years
Table 51. Respiratory Infectious Disease Diagnostics New Entrants and Expansion Plans
Table 52. Global Respiratory Infectious Disease Diagnostics Revenue (USD Million) by Type (2016-2021)
Table 53. Global Respiratory Infectious Disease Diagnostics Revenue Share by Type (2016-2021)
Table 54. Global Respiratory Infectious Disease Diagnostics Revenue Forecast by Type (2021-2026)
Table 55. Global Respiratory Infectious Disease Diagnostics Revenue by Application (2016-2021)
Table 56. Global Respiratory Infectious Disease Diagnostics Revenue Forecast by Application (2021-2026)
Table 57. North America Respiratory Infectious Disease Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Respiratory Infectious Disease Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Respiratory Infectious Disease Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Respiratory Infectious Disease Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Respiratory Infectious Disease Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Respiratory Infectious Disease Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Respiratory Infectious Disease Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Respiratory Infectious Disease Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Respiratory Infectious Disease Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Respiratory Infectious Disease Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Respiratory Infectious Disease Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Respiratory Infectious Disease Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Respiratory Infectious Disease Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Respiratory Infectious Disease Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Respiratory Infectious Disease Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Respiratory Infectious Disease Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Respiratory Infectious Disease Diagnostics Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Respiratory Infectious Disease Diagnostics Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Respiratory Infectious Disease Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Respiratory Infectious Disease Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Respiratory Infectious Disease Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Respiratory Infectious Disease Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Respiratory Infectious Disease Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Respiratory Infectious Disease Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Respiratory Infectious Disease Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Respiratory Infectious Disease Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Respiratory Infectious Disease Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Respiratory Infectious Disease Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Respiratory Infectious Disease Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Respiratory Infectious Disease Diagnostics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Respiratory Infectious Disease Diagnostics Picture
Figure 2. Global Respiratory Infectious Disease Diagnostics Revenue Market Share by Type in 2020
Figure 3. Mechanical Tests
Figure 4. Imaging Tests
Figure 5. In Vitro Diagnostics (IVD) Tests
Figure 6. Respiratory Infectious Disease Diagnostics Revenue Market Share by Application in 2020
Figure 7. Hospitals Picture
Figure 8. Clinical Laboratories Picture
Figure 9. Others Picture
Figure 10. Global Respiratory Infectious Disease Diagnostics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Respiratory Infectious Disease Diagnostics Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Respiratory Infectious Disease Diagnostics Revenue Market Share by Region (2016-2026)
Figure 13. Global Respiratory Infectious Disease Diagnostics Revenue Market Share by Region in 2020
Figure 14. North America Respiratory Infectious Disease Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Respiratory Infectious Disease Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Respiratory Infectious Disease Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Respiratory Infectious Disease Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Respiratory Infectious Disease Diagnostics Market Drivers
Figure 19. Respiratory Infectious Disease Diagnostics Market Restraints
Figure 20. Respiratory Infectious Disease Diagnostics Market Trends
Figure 21. Abbott Laboratories Recent Developments and Future Plans
Figure 22. Thermo Fisher Scientific. Recent Developments and Future Plans
Figure 23. Koninklijke Philips Recent Developments and Future Plans
Figure 24. Cardinal Health Recent Developments and Future Plans
Figure 25. COSMED Recent Developments and Future Plans
Figure 26. Smiths Group Recent Developments and Future Plans
Figure 27. NIHON KOHDEN CORPORATION Recent Developments and Future Plans
Figure 28. Becton Recent Developments and Future Plans
Figure 29. Dickinson Recent Developments and Future Plans
Figure 30. F.Hoffmann Recent Developments and Future Plans
Figure 32. Global Respiratory Infectious Disease Diagnostics Revenue Share by Players in 2020
Figure 33. Respiratory Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Respiratory Infectious Disease Diagnostics Revenue Market Share in 2020
Figure 35. Global Top 10 Players Respiratory Infectious Disease Diagnostics Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Respiratory Infectious Disease Diagnostics Revenue Share by Type in 2020
Figure 38. Global Respiratory Infectious Disease Diagnostics Market Share Forecast by Type (2021-2026)
Figure 39. Global Respiratory Infectious Disease Diagnostics Revenue Share by Application in 2020
Figure 40. Global Respiratory Infectious Disease Diagnostics Market Share Forecast by Application (2021-2026)
Figure 41. North America Respiratory Infectious Disease Diagnostics Sales Market Share by Type (2016-2026)
Figure 42. North America Respiratory Infectious Disease Diagnostics Sales Market Share by Application (2016-2026)
Figure 43. North America Respiratory Infectious Disease Diagnostics Revenue Market Share by Country (2016-2026)
Figure 44. United States Respiratory Infectious Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Respiratory Infectious Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Respiratory Infectious Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Respiratory Infectious Disease Diagnostics Sales Market Share by Type (2016-2026)
Figure 48. Europe Respiratory Infectious Disease Diagnostics Sales Market Share by Application (2016-2026)
Figure 49. Europe Respiratory Infectious Disease Diagnostics Revenue Market Share by Country (2016-2026)
Figure 50. Germany Respiratory Infectious Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Respiratory Infectious Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Respiratory Infectious Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Respiratory Infectious Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Respiratory Infectious Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Respiratory Infectious Disease Diagnostics Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Respiratory Infectious Disease Diagnostics Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Respiratory Infectious Disease Diagnostics Revenue Market Share by Region (2016-2026)
Figure 58. China Respiratory Infectious Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Respiratory Infectious Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Respiratory Infectious Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Respiratory Infectious Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Respiratory Infectious Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Respiratory Infectious Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Respiratory Infectious Disease Diagnostics Sales Market Share by Type (2016-2026)
Figure 65. South America Respiratory Infectious Disease Diagnostics Sales Market Share by Application (2016-2026)
Figure 66. South America Respiratory Infectious Disease Diagnostics Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Respiratory Infectious Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Respiratory Infectious Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Respiratory Infectious Disease Diagnostics Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Respiratory Infectious Disease Diagnostics Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Respiratory Infectious Disease Diagnostics Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Respiratory Infectious Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Respiratory Infectious Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Respiratory Infectious Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界のB型肝炎感染症検査市場規模・現状・予測（2021年-2027年） Hepatitis B is a potentially life-threatening liver infection caused by the hepatitis B virus (HBV). It is a major global health problem. It can cause chronic infection and puts people at high risk of death from cirrhosis and liver cancer. Market Analysis and Insights: Global Hepatitis B Infectious …- 世界のB型肝炎感染症検査市場規模・現状・予測（2021年-2027年） Hepatitis B is a potentially life-threatening liver infection caused by the hepatitis B virus (HBV). It is a major global health problem. It can cause chronic infection and puts people at high risk of death from cirrhosis and liver cancer. Market Analysis and Insights: Global Hepatitis B Infectious …
- 世界の感染症診断市場規模・現状・予測（2021年-2027年） Infectious-disease diagnostics is the procedure by which the causative agent of an infectious disease is identified and often characterized. Market Analysis and Insights: Global Infectious Disease Diagnostics Market The global Infectious Disease Diagnostics market size is projected to reach US$ 1687…
- 世界のポイントオブケア感染症診断市場規模・現状・予測（2021年-2027年） Point of care diagnosis allows for early detection of diseases and can greatly impact the medical outcome of the disease treatment. The point-of-care infectious disease diagnostics market is expected to register a fast growth over the forecast period owing to the emerging trend of patient-centric se…
- 世界の感染症診断市場 2021：企業別、地域別、種類・用途別 The Infectious Disease Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …